Wickham Laboratories is pleased to announce that an editorial written by our CEO, John McKenzie, has recently been published by International Pharmaceutical Industry (IPI). This article, which discusses ‘Working with Difficult Preparations: Risks, Regulations and Considerations’, written by Wickham Laboratories’ CEO John McKenzie, was published in the IPI summer issue. You can find the full article below, on […]
Wickham Laboratories Ltd is pleased to provide the results of our case study on the bioburden of the new polymer £5 note. In collaboration with European Pharmaceutical Manufacturing (EPM), Wickham Laboratories Ltd recently performed a study examining the bioburden of the new £5 polymer notes. A British £5 note is exchanged hundreds of times during […]
Wickham Laboratories is pleased to announce the publication of an Application Note, “Microbial Limits Testing: Risk Assessments for Objectionable Organisms.“ which was featured by European Pharmaceutical Review in their December issue. An abstract of this whitepaper is available below. If you are interested and would like to read in full, please log into the EPR […]
Please take note of our holiday closures.
Wickham Laboratories completes facility expansion for growing sterility department. Wickham Laboratories announces the expansion of our service offerings once again within our sterility department. Due to a marked increase in the volume of sterility testing our sterility department has been engaged in over the past year, a refurbishment project was carried out in September to […]
Wickham Laboratories will be on Stand 8 at the 24th Annual Pharmig Conference in the Nottingham Belfry Hotel, November 16th &17th. Pharmig is a non-profit organisation dedicated to facilitating discussion on the latest research and trends in the field of pharmaceutical microbiology. This year’s speakers include delegates from Public Health England and several top pharma […]